Literature DB >> 9285653

Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia.

R Hachamovitch1, D S Berman, H Kiat, I Cohen, H Lewin, A Amanullah, X Kang, J Friedman, G A Diamond.   

Abstract

We examined 1,159 consecutive patients who underwent adenosine stress dual isotope single-photon emission computed tomography (SPECT) and had follow-up performed at a mean of 27.5 +/- 9.1 months (94% complete) for hard events (cardiac death and myocardial infarction) and referral to cardiac catheterization after nuclear testing. During follow-up, 120 hard events occurred (11.0% hard event rate; 72 cardiac deaths [6.7% cardiac death rate] and 57 myocardial infarctions [5.3% myocardial infarction rate]). Cox proportional hazards analysis revealed that nuclear testing added incremental value after adjusting for clinical and historical variables (global chi-square increased 13 to 98 for cardiac death as the end point, global chi-square increased 19 to 105 for hard events as the end point; p <0.0001 for both). Kaplan-Meier analysis demonstrated that after clinical risk stratification of the patient population, the results of nuclear testing were further able to significantly stratify both low- and intermediate- to high-risk patients. Patients with both normal and mildly abnormal scans were at low risk of cardiac death (<1% cardiac death per year of follow-up) and the risk of events increased significantly with worsening scan result. Multivariable analysis revealed that the only predictor of referral to catheterization was the extent and severity of reversible defect present on the scan. Referral rates to early catheterization were very low in patients with normal scans and increased significantly as a function of worsening scan results. In patients who underwent myocardial perfusion SPECT using adenosine stress, the results of nuclear testing yielded incremental prognostic information and clinically relevant risk stratification. Referring physicians predominantly utilized nuclear information when referring patients to catheterization after nuclear testing and do so at rates comparable with those after exercise SPECT despite the higher risk of events in patients undergoing pharmacologic stress.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285653     DOI: 10.1016/s0002-9149(97)00390-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  51 in total

1.  Diagnostic and prognostic applications for vasodilator stress myocardial perfusion imaging and the importance of radiopharmaceutical selection.

Authors:  R C Hendel
Journal:  J Nucl Cardiol       Date:  2001 Jul-Aug       Impact factor: 5.952

2.  Prognostic value of automated vs visual analysis for adenosine stress myocardial perfusion SPECT in patients without prior coronary artery disease: a case-control study.

Authors:  Yuan Xu; Ryo Nakazato; Sean Hayes; Rory Hachamovitch; Victor Y Cheng; Heidi Gransar; Romalisa Miranda-Peats; Mark Hyun; Leslee J Shaw; John Friedman; Guido Germano; Daniel S Berman; Piotr J Slomka
Journal:  J Nucl Cardiol       Date:  2011-09-20       Impact factor: 5.952

Review 3.  An overview of contemporary nuclear cardiology.

Authors:  Howard C Lewin; Maria G Sciammarella; Thomas A Watters; Herbert G Alexander
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

4.  Risk stratification of the normal perfusion scan: does normal stress perfusion always mean very low risk?

Authors:  Seth Dahlberg; Jeffrey Leppo
Journal:  J Nucl Cardiol       Date:  2003 Jan-Feb       Impact factor: 5.952

5.  Antianginal medications and diagnostic accuracy of myocardial perfusion imaging.

Authors:  Nikant Kumar Sabharwal; Avijit Lahiri
Journal:  J Nucl Cardiol       Date:  2003 Jul-Aug       Impact factor: 5.952

Review 6.  Prognostic value of gated myocardial perfusion SPECT.

Authors:  Leslee J Shaw; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

Review 7.  Quantitative analysis of perfusion studies: strengths and pitfalls.

Authors:  Piotr Slomka; Yuan Xu; Daniel Berman; Guido Germano
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

8.  SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value.

Authors:  W Lane Duvall; Lori B Croft; Jared S Corriel; Andrew J Einstein; Jonathan E Fisher; Pilar S Haynes; Randi K Rose; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 9.  Nuclear stress testing in elderly patients: a review of its use in the assessment of cardiac risk, particularly in patients undergoing preoperative risk assessment.

Authors:  Amgad N Makaryus; Joseph A Diamond
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 10.  Role of myocardial perfusion imaging for risk stratification in suspected or known coronary artery disease.

Authors:  N K Sabharwal; A Lahiri
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.